GWLL · Goldenwell Biotech, Inc.
$0.65
At close · Oct 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company's continuation as a going concern is dependent upon, among other things, its ability to generate revenues and its ability to obtain capital from third parties. No assurance can be given that the Company will be successful in these efforts.”View the 10-Q filed Aug 14, 2026
Market Cap
$64.35M
Shares
99.00M
Volume · Oct 19
802
Avg daily vol (6 sessions)
739
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.65
Open$0.65
Day$0.65–0.65
52W close$0.51–7.00
Avg vol 30d928
Short int16 · 0.0% float · 1.0d
Short vol90%
DataSep 2022–Oct 2026
Filing10-Q · Aug 14
Up next
filed Aug 14, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$55
Trailing 12 months
Net income (TTM)
−$282,117
Trailing 12 months
Revenue growth YoY
-60.4%
Year over year
Operating margin
-208,729.1%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.0%
Year over year
Price change (1Y)
—
Trailing year
Short interest
—
Latest settlement
Quarterly results
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 17.3 · elevated
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−57%
below
RSI (14)
42
neutral
MACD trend
Negative
52-week position
2%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−48%
trailing
YTD return
−78%
this year
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Fundamentals
Revenue growth
−60%
Y/Y
Gross margin
22%
contracting
Quant / Vol
risk profile
Volatility
1624%
annualized · 1-yr
Max drawdown
−93%
past year
ATR
45.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−57%
Bearish
RSI (14)
42
Neutral
MACD trend
Negative
Bearish
52-week position
2%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $1
Now $1 · 2%
Range high $7
vs 50-day avg -57%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Packaged Foods — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GWLL
this stock
Goldenwell Biotech, Inc.
|
$64.35M | -77.6% | -60.4% | — | 0.0% |
|
JBS
Jbs N.V.
|
$42.43B | -11.9% | — | — | 1.3% |
|
KHC
Kraft Heinz Co
|
$27.48B | -1.7% | -0.1% | — | 7.8% |
|
GIS
General Mills Inc
|
$17.87B | -28.1% | +4.1% | — | 7.7% |
|
SJM
J M SMUCKER Co
|
$13.57B | +32.6% | +3.7% | — | 4.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
SEC Filings
Latest
8-K
- Filed
- Oct 9, 2026
- This year
- 11
Goldenwell Biotech, Inc. appointed Ming Zhou as a director on October 8, 2026, expanding the board to four members. Chief Executive Officer and director Shuang Liu gifted Zhou 20,000,000 common shares, equivalent to approximately 20.2% of issued and outstanding shares.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GWLL | -15.6% | -48.0% | — | -5.8% | -77.6% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | -14.1% | -47.1% | — | -6.3% | -90.0% |